Michael J. Detke M.D., Ph.D.
Net Worth

Last updated:

What is Michael J. Detke M.D., Ph.D. net worth?

The estimated net worth of Dr. Michael J. Detke M.D., Ph.D. is at least $6,091,184 as of 10 Aug 2021. He owns shares worth $26,259 as insider, has earned $3,194,925 from insider trading and has received compensation worth at least $2,870,000 in Cortexyme, Inc..

What is the salary of Michael J. Detke M.D., Ph.D.?

Dr. Michael J. Detke M.D., Ph.D. salary is $574,000 per year as Chief Medical Officer in Cortexyme, Inc..

How old is Michael J. Detke M.D., Ph.D.?

Dr. Michael J. Detke M.D., Ph.D. is 58 years old, born in 1967.

What stocks does Michael J. Detke M.D., Ph.D. currently own?

As insider, Dr. Michael J. Detke M.D., Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Cortexyme, Inc. (CRTX) Chief Medical Officer 13,466 $1.95 $26,259

What does Cortexyme, Inc. do?

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

CRTX logo
CRTX
Cortexyme, Inc.
$1.95

Michael J. Detke M.D., Ph.D. insider trading

Cortexyme, Inc.

Dr. Michael J. Detke M.D., Ph.D. has made 5 insider trades between 2020-2021, according to the Form 4 filled with the SEC. Most recently he sold 10,000 units of CRTX stock worth $22,300 on 10 Aug 2021.

The largest trade he's ever made was exercising 40,861 units of CRTX stock on 6 Jul 2021. As of 10 Aug 2021 he still owns at least 13,466 units of CRTX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 10,000 $2.23 $22,300
Option
Stock Option (right to buy) 10,000 $2.23 $22,300
Option
Common Stock 10,000 $2.23 $22,300
Sale
Common Stock 17,400 $55.25 $961,350
Option
Common Stock 17,400 N/A N/A
Option
Stock Option (right to buy) 17,400 N/A N/A
Sale
Common Stock 17,400 N/A N/A
Sale
Common Stock 40,861 $54.12 $2,211,275
Option
Stock Option (right to buy) 12,600 N/A N/A
Sale
Common Stock 40,861 N/A N/A
Option
Common Stock 12,600 N/A N/A
Option
Common Stock 5,515 $6.91 $38,109
Option
Stock Option (Right to Buy) 5,515 $6.91 $38,109
Option
Common Stock 5,515 $6.91 $38,109
Option
Stock Option (Right to Buy) 5,515 $6.91 $38,109
Option
Common Stock 17,231 $6.91 $119,066
Option
Stock Option (Right to Buy) 17,231 $6.91 $119,066

Cortexyme key executives

Cortexyme, Inc. executives and other stock owners filed with the SEC: